• Home
  • Study Details
Open

Eosinophilic Gastritis Study

We are trying to see whether Dupixent is a potential treatment for kids and adults with Eosinophilic Gastritis.

Age & Gender

  • 12 years ~ 99 years
  • Male, Female, Gender Inclusive

Visit Availability

  • Standard business hours (M-F, 8-5)

Location

United States (Nationwide)

What will be asked of you

At each visit, you will meet the study team at UNC's campus to receive the study drug or placebo injection. The assessments needed at each visit vary, but generally consist of: blood draws, urine samples, ECG, vital signs, and questionnaires. There will also be study endoscopies.

Incentives

Between $100-150 per visit

In-person visits:
About 22
Total length of participation:
About 1.3 years

Looking for Specific Volunteers

Able to participate:

  • Eosinophilic Gastritis

Not eligible if:

  • Pregnant

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Evan Dellon
Center for Gastrointestinal Biology and Disease

Study Type

Clinical or Medical
Interventional

Study Topics

Allergy
Stomach, Digestion and Gut Health
Rare Diseases

IRB Number

23-2246

ClinicalTrials.gov

NCT05831176

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research